Dehydroepiandrosterone to Enhance Physical Performance: Myth and Reality

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 1, 2010, Pages 127-139

  Hahner, Stefanie ^a   Allolio, Bruno ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adrenal insufficiency; Androgens; Body composition; Bone; DHEA; Doping; Physical performance; Testosterone

Indexed keywords

ANDROGEN; GLUCOCORTICOID; INSULIN; LIPID; PLACEBO; PRASTERONE; SEX HORMONE; SOMATOMEDIN C;

ACNE; ADRENAL CORTEX; ADRENAL INSUFFICIENCY; AGING; ALOPECIA; BODY COMPOSITION; BONE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; EXERCISE; HIRSUTISM; HORMONE ACTION; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; INSULIN SENSITIVITY; MUSCLE FUNCTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; SPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL INSUFFICIENCY; AGED; AGED, 80 AND OVER; AGING; ANABOLIC AGENTS; ATHLETIC PERFORMANCE; BODY COMPOSITION; BONE DENSITY; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOPING IN SPORTS; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS;

EID: 74049151106     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.10.008     Document Type: Review

References (67)

1. Orentreich N., Brind J.L., Rizer R.L., et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59 (1984) 551
2. Reiter E.O., Fuldauer V.G., and Root A.W. Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. J Pediatr 90 (1977) 766
3. Orentreich N., Brind J.L., Vogelman J.H., et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75 (1992) 1002
4. Parker Jr. C.R., Mixon R.L., Brissie R.M., et al. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 82 (1997) 3898
5. Bird C.E., Masters V., and Clark A.F. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med 7 (1984) 119
6. Hammer F., Subtil S., Lux P., et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 90 (2005) 3600
7. Martel C., Melner M.H., Gagne D., et al. Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 104 (1994) 103
8. Labrie F. Intracrinology. Mol Cell Endocrinol 78 (1991) C113
9. Arlt W., Callies F., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 (1999) 1013
10. Arlt W., Justl H.G., Callies F., et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83 (1928) 1998
11. Compagnone N.A., Bulfone A., Rubenstein J.L., et al. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136 (1995) 5212
12. Corpechot C., Robel P., Axelson M., et al. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A 78 (1981) 4704
13. Bergeron R., de Montigny C., and Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16 (1996) 1193
14. Majewska M.D., Demirgoren S., Spivak C.E., et al. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res 526 (1990) 143
15. Steckelbroeck S., Watzka M., Lutjohann D., et al. Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7alpha-hydroxylase and 17-ketosteroid reductase activity in the human brain. J Neurochem 83 (2002) 713
16. Zwain I.H., and Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 (1999) 3843
17. Liu D., and Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem 277 (2002) 21379
18. Simoncini T., Mannella P., Fornari L., et al. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144 (2003) 3449
19. Williams M.R., Ling S., Dawood T., et al. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87 (2002) 176
20. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 4 (2005) 377
21. Bilger M., Speraw S., LaFranchi S.H., et al. Androgen replacement in adolescents and young women with hypopituitarism. J Pediatr Endocrinol Metab 18 (2005) 355
22. Flynn M.A., Weaver-Osterholtz D., Sharpe-Timms K.L., et al. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 84 (1999) 1527
23. Gurnell E.M., Hunt P.J., Curran S.E., et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93 (2008) 400
24. Hunt P.J., Gurnell E.M., Huppert F.A., et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85 (2000) 4650
25. Johannsson G., Burman P., Wiren L., et al. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87 (2002) 2046
26. Brooke A.M., Kalingag L.A., Miraki-Moud F., et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 91 (2006) 3773
27. van Thiel S.W., Romijn J.A., Pereira A.M., et al. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90 (2005) 3295
28. Lovas K., Gebre-Medhin G., Trovik T.S., et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88 (2003) 1112
29. Dhatariya K., Bigelow M.L., and Nair K.S. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54 (2005) 765
30. Kahn A.J., Halloran B., Wolkowitz O., et al. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab 87 (2002) 1544
31. Callies F., Fassnacht M., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 86 (1968) 2001
32. Labrie F., Diamond P., Cusan L., et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82 (1997) 3498
33. Christiansen J.J., Gravholt C.H., Fisker S., et al. Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism. Eur J Endocrinol 152 (2005) 77
34. Libe R., Barbetta L., Dall'Asta C., et al. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 27 (2004) 736
35. Srinivasan M., Irving B.A., Dhatariya K., et al. Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women. J Clin Endocrinol Metab 94 (2009) 761
36. Tan K.C., Shiu S.W., Pang R.W., et al. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Clin Endocrinol (Oxf) 48 (1998) 187
37. Dhatariya K.K., Greenlund L.J., Bigelow M.L., et al. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo Clin Proc 83 (2008) 1218
38. Christiansen J.J., Andersen N.H., Sorensen K.E., et al. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin Endocrinol (Oxf) 66 (2007) 426
39. Rice S.P., Agarwal N., Bolusani H., et al. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J Clin Endocrinol Metab 94 (1966) 2009
40. Mease P.J., Ginzler E.M., Gluck O.S., et al. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol 32 (2005) 616
41. Sanchez-Guerrero J., Fragoso-Loyo H.E., Neuwelt C.M., et al. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol 35 (2008) 1567
42. Abbasi A., Duthie Jr. E.H., Sheldahl L., et al. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc 46 (1998) 263
43. Ravaglia G., Forti P., Maioli F., et al. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab 81 (1996) 1173
44. Casson P.R., Santoro N., Elkind-Hirsch K., et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 70 (1998) 107
45. Jankowski C.M., Gozansky W.S., Schwartz R.S., et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 91 (2006) 2986
46. Morales A.J., Haubrich R.H., Hwang J.Y., et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 49 (1998) 421
47. Morales A.J., Nolan J.J., Nelson J.C., et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78 (1994) 1360
48. Villareal D.T., and Holloszy J.O. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292 (2004) 2243
49. von Muhlen D., Laughlin G.A., Kritz-Silverstein D., et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int 19 (2008) 699
50. Weiss E.P., Shah K., Fontana L., et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr 89 (2009) 1459
51. Baulieu E.E. Dehydroepiandrosterone (DHEA): a fountain of youth?. J Clin Endocrinol Metab 81 (1996) 3147
52. Baulieu E.E., Thomas G., Legrain S., et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 97 (2000) 4279
53. Nair K.S., Rizza R.A., O'Brien P., et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355 (2006) 1647
54. Villareal D.T., Holloszy J.O., and Kohrt W.M. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) 53 (2000) 561
55. Jankowski C.M., Gozansky W.S., Kittelson J.M., et al. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. J Clin Endocrinol Metab 93 (2008) 4767
56. Diamond P., Cusan L., Gomez J.L., et al. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150 Suppl (1996) S43
57. Percheron G., Hogrel J.Y., Denot-Ledunois S., et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med 163 (2003) 720
58. Villareal D.T., and Holloszy J.O. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab 291 (2006) E1003
59. Igwebuike A., Irving B.A., Bigelow M.L., et al. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab 93 (2008) 534
60. Reeder B.M., Rai A., Patel D.R., et al. The prevalence of nutritional supplement use among high school students: a pilot study. Med Sci Sports Exerc 34 (2002) 193
61. Calfee R., and Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics 117 (2006) e577
62. Mareck U., Geyer H., Flenker U., et al. Detection of dehydroepiandrosterone misuse by means of gas chromatography-combustion-isotope ratio mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) 13 (2007) 419
63. Nestler J.E., Barlascini C.O., Clore J.N., et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66 (1988) 57
64. Welle S., Jozefowicz R., and Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab 71 (1990) 1259
65. Wallace M.B., Lim A., Cutler A., et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc 31 (1999) 1788
66. Brown G.A., Vukovich M.D., Sharp R.L., et al. Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J Appl Phys 87 (1999) 2274
67. Stanczyk F.Z., Slater C.C., Ramos D.E., et al. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women. Menopause 16 (2009) 272